Bradley Foster & Sargent Inc Rx Sight, Inc. Transaction History

Bradley Foster & Sargent Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$50.42 - $64.29 $27,327 - $34,845	-542 Reduced 2.1%	25,270 $1.52 Million
Q1 2024 May 15, 2024	SELL	$35.51 - $57.92 $463,227 - $755,566	-13,045 Reduced 33.57%	25,812 $1.33 Million
Q4 2023 Feb 14, 2024	SELL	$20.91 - $40.9 $386,354 - $755,709	-18,477 Reduced 32.23%	38,857 $1.57 Million
Q1 2023 May 08, 2023	SELL	$12.58 - $16.68 $2,201 - $2,919	-175 Reduced 0.3%	57,334 $956,000
Q4 2022 Feb 14, 2023	BUY	$9.93 - $14.2 $1,737 - $2,485	175 Added 0.31%	57,509 $728,000
Q3 2022 Nov 14, 2022	BUY	$11.19 - $15.85 $14,155 - $20,050	1,265 Added 2.26%	57,334 $688,000
Q2 2022 Aug 11, 2022	BUY	$10.61 - $16.66 $305,323 - $479,424	28,777 Added 105.44%	56,069 $789,000
Q1 2022 May 16, 2022	SELL	$8.97 - $14.03 $35,709 - $55,853	-3,981 Reduced 12.73%	27,292 $338,000
Q4 2021 Mar 11, 2022	BUY	$9.52 - $13.81 $5,664 - $8,216	595 Added 1.94%	31,273 $352,000
Q3 2021 Nov 10, 2021	BUY	$11.85 - $17.32 $363,534 - $531,342	30,678 New	30,678 $389,000

225

32.3M

394K

32K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.05B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

Stay updated on Bradley Foster & Sargent Inc with notifications on news.